Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,052 | -908 | -2,105 | -190 | N/A |
| Depreciation Amortization | 387 | 395 | 376 | 353 | N/A |
| Accounts receivable | -504 | -149 | 26 | -72 | N/A |
| Accounts payable and accrued liabilities | -34 | 104 | -56 | 190 | N/A |
| Other Working Capital | -1,102 | -88 | -347 | -177 | N/A |
| Other Operating Activity | 642 | 250 | 184 | 42 | 0 |
| Operating Cash Flow | $-2,662 | $-396 | $-1,921 | $145 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -169 | -185 | -418 | -90 | N/A |
| Purchase Sale Intangibles | -30 | N/A | -78 | N/A | N/A |
| Other Investing Activity | -30 | 5 | -78 | 0 | 0 |
| Investing Cash Flow | $-199 | $-180 | $-496 | $-90 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -113 | N/A |
| Common Stock Issued | 4,678 | N/A | 4,273 | 3 | N/A |
| Common Stock Repurchased | N/A | N/A | -960 | N/A | N/A |
| Other Financing Activity | -63 | -79 | -75 | -67 | 0 |
| Financing Cash Flow | $4,616 | $-79 | $3,239 | $-176 | $N/A |
| Beginning Cash Position | 471 | 1,126 | 304 | 425 | N/A |
| End Cash Position | 2,227 | 471 | 1,126 | 304 | N/A |
| Net Cash Flow | $1,755 | $-654 | $822 | $-121 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,662 | -396 | -1,921 | 145 | N/A |
| Capital Expenditure | -169 | -185 | -418 | -90 | N/A |
| Free Cash Flow | -2,831 | -581 | -2,339 | 55 | 0 |